We are a bioincubator helping emerging biotechs decreasing their time to seed funding.
We have a growing commitment to engineering innovation that improves industrial efficiency.
Our Programs
We are the seed accelerator of Charleroi Brussels South Biopark
ULB researchers have identified tumor cell populations responsible for metastasis
In a study published in Nature, research team led by Prof. Cédric Blanpain, MD/PhD, WELBIO investigator and Professor at the Université libre de Bruxelles, Belgium, identified for the first time, the different tumor transition states occurring during cancer progression and identified subpopulations of tumor cells responsible for metastasis in skin squamous cell carcinoma, the second most frequent cancer worldwide, and breast cancer, the most frequent cancers in women. Please find the official press release of ULB here.
Spectralys Biotech is looking for a Business Developer
Spectralys Biotech, an in-creation ULB spin-off offering innovative analytical solutions for biomolecules based on infrared spectroscopy (FTIR), is looking for a Business Developer to promote adoption of its technology in the biopharmaceutical industry. Interested? Please find the job offering and contact details here.
Read moreMedTech Booster
Market opportunity validation
This one day booster aims at advising early stage MedTech projects on how to conduct a professional market validation...
Read more